Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
6.21Price to Sales
VS
Market
Sector
Industry
History
$ 9.84Close
$ 5.54 - $ 18.57 52-Week Range
Ticker Information
Ticker
KURACompany Name
KURA ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKURA ONCOLOGY INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KURA - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 517.31M | 6.21 | $ 83.28M |
| 3/31/2025 | $ 561.87M | 8.26 | $ 67.99M |
| 12/31/2024 | $ 622.62M | 11.56 | $ 53.88M |
| 9/30/2024 | $ 1.38B | 0 | $ 0 |
| 6/30/2024 | $ 1.47B | 0 | $ 0 |
| 3/31/2024 | $ 1.57B | 0 | $ 0 |
| 12/31/2023 | $ 1.66B | 0 | $ 0 |
| 9/30/2023 | $ 625.37M | 0 | $ 0 |
| 6/30/2023 | $ 798.78M | 0 | $ 0 |
| 3/31/2023 | $ 783.62M | 0 | $ 0 |
Key Performance Insights, Last 5 Years
- KURA ONCOLOGY INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, KURA ONCOLOGY INC's average P/S has been 8.68.
- The median P/S for KURA ONCOLOGY INC during this period was 8.26
- KURA ONCOLOGY INC reached its highest P/S over the past 5 years at 11.56.
- The lowest P/S recorded by KURA ONCOLOGY INC in the same timeframe 6.21
KURA ONCOLOGY INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for KURA ONCOLOGY INC is calculated as follows: Market Cap [ $ 1.98B ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] KURA - Price to Sales, Last 5 years
6.21
Minimum
Jun 30, 2025
11.56
Maximum
Dec 31, 2024
8.68
Average
8.26
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |